LAVAL, QUEBEC--(Marketwire - April 21, 2009) - Warnex Inc. (TSX: WNX) invites all interested parties to attend its Annual Meeting of Shareholders.
Date: Tuesday, April 28, 2009 Time: 11:00 am (EST) Location: Sheraton Laval, Salon Auteuil-Vimont 2440 Autoroute des Laurentides Laval, Quebec
In addition to the formal business described in the Management Information Circular, Mark Busgang, President and CEO of Warnex, will present an update on corporate activities.
About Warnex
Warnex (www.warnex.ca) is a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical and healthcare sectors. Warnex’s analytical services division provides pharmaceutical and biotechnology companies with a variety of quality control services, including traditional chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex’s bioanalytical services division specializes in bioequivalence and bioavailability studies for clinical trials. Warnex’s medical laboratories division focuses on genetic and biochemical testing for the healthcare industry and has extensive expertise in genetic testing for human identification, molecular diagnostics, and pharmacogenetics.
Contacts:
Warnex Inc.
Mark J. Busgang
President & CEO
450-663-6724 x 310
mbusgang@warnex.ca
Warnex Inc.
Catherine Sartoros
Communications Specialist
450-663-6724 x 277
csartoros@warnex.ca